Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancer

Venter, 1987, Overexpression of the c-erbB-2 onco-protein in human breast carcinomas: immunohistological assessment correlates with gene amplification, Lancet, ii, 69, 10.1016/S0140-6736(87)92736-X Slamon, 1989, Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science, 244, 702, 10.1126/science.2470152 Fukushighe, 1986, Localisation of novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line, Mol Cell Bio, 6, 955, 10.1128/MCB.6.3.955 Cohen, 1989, Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract, Oncogene, 4, 81 Falck, 1989, c-erbB-1 oncogene product staining in gastric adenocarcinoma. An irrununohistochemical study, J Pathol, 159, 107, 10.1002/path.1711590204 Semba, 1985, A v-erbB related proto-oncogene, c-erbB-2, is distinct from c-erbB-1/epidermal growth factor receptor gene and is amplified in a human salivary gland adenocarcinoma, Proc Natl Acad Sci USA, 82, 6497, 10.1073/pnas.82.19.6497 Yokota, 1986, Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo, Lancet, i, 765, 10.1016/S0140-6736(86)91782-4 Meltzer, 1987, Proto-on-cogene abnormalities in colon cancers and adenomatous polyps, Gastroenterology, 92, 1174, 10.1016/S0016-5085(87)91074-2 Schneider, 1989, Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer, Cancer Research, 49, 4968 Gusterson, 1988, c-erbB-2 expression in benign and malignant breast disease, Br J Cancer, 58, 453, 10.1038/bjc.1988.239 Berger, 1988, c-erbB-2 gene amplification and protein expression in human breast carcinoma correlates with nodal status and nuclear grading, Cancer Res, 48, 1238 Barnes, 1988, An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma, Br J Cancer, 58, 448, 10.1038/bjc.1988.238 Lacroix, 1989, Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases, Oncogene, 4, 145 Guerin, 1989, Expression of protoon-cogenes c-myc or c-erbB-2 in cancers of the breast: Clinical implications, Bull Cancer, 76, 175 Guerin, 1989, Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer prognostic significance, Int J Cancer, 43, 201, 10.1002/ijc.2910430205 Varley, 1987, Alterations to either c-erbB-2 (neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis, On-cogene, 1, 423 Zhou, 1987, Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer, Cancer Res, 47, 6123 van de Vijver, 1988, Neu protein overexpression in breast cancer. Association with comedotype ductal carcinoma in situ and limited prognostic value in stage II breast cancer, N Engl J Med, 319, 1239, 10.1056/NEJM198811103191902 Gusterson, 1988, McKinna A, Harrison S. Immunochistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer, Int J Cancer, 42, 842, 10.1002/ijc.2910420608 Slamon, 1987, Human breast cancer correlation of relapse and survival with amplification of the HER-2 neu oncogene, Science, 235, 177, 10.1126/science.3798106 De Potter, 1989, The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues, Histopathology, 15, 351, 10.1111/j.1365-2559.1989.tb01587.x De Potter, 1989, The subcellular localization of the neu protein in human normal and neoplastic cells, Int J Cancer, 44, 969, 10.1002/ijc.2910440604 van de Vijver, 1988, Immunohistochemical detection of the neu protein in tissue sections of human breast tumours with amplified neu DNA, Oncogene, 2, 175 Gusterson, 1987, Immunohistochemical localization of c-erbB-2 in human breast carcinomas, Mol Cell Probes, 1, 383, 10.1016/0890-8508(87)90019-3 Paik, 1990, Pathologic findings from the national surgical adjuvant breast and bowel project: prognostic significance of erbB-2 protein overexpression in primary breast cancer, J Clin Oncol, 8, 103, 10.1200/JCO.1990.8.1.103 Wright, 1989, Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer, Cancer Res, 49, 2087 van de Vijver, 1987, Amplification of the neu (c-crbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbBA oncogene, Mol Cell Biol, 7, 2019, 10.1128/MCB.7.5.2019 Ramachandra S, Machin L, Ashley S, Gusterson BA. Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma. J Pathol (In press). Barnes, 1989, High incidence of c-erbB-2 protein in mammary ductal carcinoma in situ of comedo pattern. Proceedings of Pathological Society, J Pathol, 157, 164A Barnes, 1988, Paget's disease of the nipple shows a high incidence of expression of c-erbB-2 protein, Breast Cancer Res Treatment, 12, 138 Berger, 1988, Correlation of c-erbB-2 gene amplification and protein expression in human breast car-cinoma with nodal status and nuclear grading, Cancer Res, 48, 1233 Ro, 1989, c-erbB-2 amplification in node negative breast cancer: a positive relation with nuclear anaplasia and DNA aneuploidy. A possible prognostic factor, Lab Invets, 60, 78A Walker, 1989, An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer, Br J Cancer, 60, 426, 10.1038/bjc.1989.299 Bargmann, 1986, The neu oncogene encodes an epidermal growth factor receptor-related protein, Nature, 319, 226, 10.1038/319226a0 Coussens, 1985, Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene, Science, 230, 1132, 10.1126/science.2999974 Tandon, 1989, Her-2/neu oncogene protein and prognosis in breast cancer, J Clin Oncol, 7, 1120, 10.1200/JCO.1989.7.8.1120 Tsuda, 1989, Sakamoto H, Terada M, Sugimura T. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-l/int-2 and c-erbB-2/ear-l1, Cancer Res, 49, 3104 Vartey, 1987, Alterations to either c-erbB-2 (neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis, On-cogene, 1, 423 Hedley, 1987, Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer, Cancer Research, 47, 4729 Ludwig Breast Cancer Study Group., 1985, A randomized trial of adjuvant combination chemotherapy, with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes, Cancer Research, 45, 4454 Ludwig Breast Cancer Study Group., 1984, Randomized trial of chemoendocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastases, Lancet, 1, 1256 Ludwig Breast Cancer Study Group., 1985, Chemotherapy with or without oophorectomy in high-risk premenopausal patients with operable breast cancer, Journal of Clinical Oncology, 3, 1059, 10.1200/JCO.1985.3.8.1059 Gelber, 1985, Planning and reporting of clinical trials. In: Textbook of Medical Oncology. Calabresi P, Rosenberg SA, and Schein P. (eds), MacMillan Publishing Co., New York, 13, 406 Cox, 1972, Regression models and life tables (with discussion), J R Statistical Soc (Ser B), 34, 187